Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults

Archives of Internal Medicine

Volumn 158, Issue 17, 1998, Pages 1855-1867

  Donato, Karen A ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXFENFLURAMINE; FENFLURAMINE; PHENTERMINE; SIBUTRAMINE; TETRAHYDROLIPSTATIN;

ADULT; ARTICLE; BEHAVIOR THERAPY; BODY MASS; CALORIC RESTRICTION; CLINICAL TRIAL; EVIDENCE BASED MEDICINE; HUMAN; MORBIDITY; MORTALITY; OBESITY; PHYSICAL ACTIVITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; SOCIAL ASPECT; SURGERY; UNITED STATES; VALVULAR HEART DISEASE; WEIGHT REDUCTION;

BEHAVIOR THERAPY; BODY MASS INDEX; EVIDENCE-BASED MEDICINE; HUMANS; LIFE STYLE; OBESITY; RISK; RISK FACTORS; SEVERITY OF ILLNESS INDEX; UNITED STATES; WEIGHT LOSS;

EID: 0032575852     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.158.17.1855     Document Type: Article

References (4)

1. Kuczmarski RJ, Carrol MD, Flegal KM, Troiano RP. Varying body mass index cutoff points to describe overweight prevalence among US adults: NHANES III (1988-1994). Obes Res. 1997;5:542-548.
2. Flegal KM, Carrol MD, Kuczmarski RJ, Johnson CL. Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int J Obes. 1998;22:39-47.
3. National Cholesterol Education Program. Second report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation. 1994;89:1333-1445.
4. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI). Arch Intern Med. 1997;157:2413-2446.